Alopexx, Inc.
Letter · prints on one page
Company tear sheetData as of Nov 7, 2026
Company · Healthcare · Biological Products, (No Diagnostic Substances)

Alopexx, Inc.

CIK 1880995 · Latest: IPO · Filed, Mar 7, 2022

Acquisitions0
Sale processNoneNot a target
Banks used0
IPOFiled$33M · filed Mar 7, 2022

Advisors and underwriters

No advisors named in Castle's filings.

Activist investors

No activist 13D filings since late 2024.

Sources
  • S-1/A · Nov 6, 2026
  • S-1 · Mar 7, 2022

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.